Myovant stock opened 35% up on Monday: here’s the catalyst

Myovant Sciences Ltd (NYSE: MYOV) opened nearly 35% up on Monday after the biopharmaceutical company said it rejected a buyout proposal from its largest shareholder. Myovant is open to considering a b...

Credit Suisse, Tesla, Myovant Sciences and more

Take a look at some of the biggest movers in the premarket: Credit Suisse (CS) – Credit Suisse slid 6.1% in premarket trading after the bank sought to calm the fears of investors and clients about its...

Myovant Sciences provides an update on a supplemental new drug

Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced an update for an sNDA for MYFEMBREE, which is designed to manage severe to moderate pain linked to endometriosis. According to the ongoin...